Form 8-K - Current report:
SEC Accession No. 0001628280-21-006250
Filing Date
2021-03-31
Accepted
2021-03-31 16:02:33
Documents
16
Period of Report
2021-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cerc-20210325.htm   iXBRL 8-K 40561
2 EX-99.1 ex-991prgloballicenseagree.htm EX-99.1 17228
8 image_11.jpg GRAPHIC 30797
  Complete submission text file 0001628280-21-006250.txt   244524

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20210325.xsd EX-101.SCH 2458
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20210325_cal.xml EX-101.CAL 744
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20210325_def.xml EX-101.DEF 1689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20210325_lab.xml EX-101.LAB 23312
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20210325_pre.xml EX-101.PRE 12151
9 EXTRACTED XBRL INSTANCE DOCUMENT cerc-20210325_htm.xml XML 9975
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 21793185
SIC: 2834 Pharmaceutical Preparations